Erica Schwartz's CDC Nomination Shifts Focus Away from Controversial Vaccine Policies
U.S. Health Secretary Robert F. Kennedy Jr. supports Erica Schwartz's nomination as the CDC director. Her selection marks a strategic shift away from Kennedy's contentious vaccine policies, aiming to focus on more popular health issues. Schwartz previously served as deputy surgeon general during the COVID-19 pandemic.
U.S. Health Secretary Robert F. Kennedy Jr. announced to senators on Wednesday that if confirmed, Erica Schwartz will independently make decisions as the incoming CDC director.
This nomination indicates a strategic shift from Kennedy's controversial vaccine policies, as the administration turns to popular issues like drug price reduction.
Schwartz, deputy surgeon general during COVID-19, is seen as a traditional choice. The decision comes amid lingering tensions over past vaccine policy disagreements at the CDC.
ALSO READ
-
Erica Schwartz's Controversial CDC Nomination Amid Vaccine Policy Disputes
-
Erica Schwartz's CDC Nomination: A New Direction Amid Vaccine Policy Turmoil
-
Tumultuous Turnover: Trump Nominates Erica Schwartz for CDC Leadership
-
Trump Nominates Erica Schwartz as CDC Director Amid Vaccine Policy Controversies
-
Trump Chooses Erica Schwartz for CDC Leadership Amid Vaccine Controversy
Google News